Floatz logo

CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE

Genital Diseases, Male

Small moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

3 Active assets in the Genital Diseases, Male cohort.

Asset / SponsorPhaseRating
Fluciclovine
VA Greater Los Angeles Healthcare System
Phase 4BB
STI571
Novartis Pharmaceuticals
Phase 2B
PSMA-HBED-CC ALF-18
Alessandro D'Agnolo
Phase 2B
Ixabepilone
Cedars-Sinai Medical Center
Phase 2CCC
Darolutamide
Celcuity Inc
Phase 1/2CCC

View all 9 →

Same molecule, other indications

CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE is also rated in:

infantile spasmsDormant
BBB
Indicative ·
79 / 100
View asset →
non-Hodgkin lymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
castration-resistant prostate carcinomaDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →